FSTX: F-star Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

F-star Therapeutics, Inc.

NASDAQ:FSTX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$7.12
Loss Chance
54.3%
2.09JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.28
$29.44
45.29%
Dynavax Technologies Corporation
NASDAQ:DVAX
4.69
$15.50
49.83%
Eagle Pharmaceuticals
NASDAQ:EGRX
3.69
$3.19
93.14%
Genmab A/S
NASDAQ:GMAB
6.50
$26.79
6.50%
Genfit S.A.
NASDAQ:GNFT
1.61
$4.80
100.00%
Jitta Factors
Growth Opportunity (26)
Recent Business Performance (56)
Financial Strength (41)
Return to Shareholders (8)
Competitive Advantage (36)
Jitta Signs
Recent IPOLess than 3 years
Operating MarginInconsistent
Recent Business PerformanceEarning decline 79.53% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
2.09
100.00%
2.24
184.44%
3.07
413.44%
Biotechnology
6.28
45.29%
4.69
49.83%
3.69
93.14%
COMPANY DESCRIPTION
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company’s principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom. As of March 8, 2023, F-star Therapeutics, Inc. operates as a subsidiary of invoX Pharma Limited.
www.f-star.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.